T wo Stent Strategy with DES and BVS for Left Main Bifurcation - PowerPoint PPT Presentation

Sep 01, 2022 •298 likes •482 views

T wo Stent Strategy with DES and BVS for Left Main Bifurcation Treatment Indulis Kumsars, MD Latvian Centre of Cardiology Latvia Clinical Characteristics Male 69 y.o. Stable angina CSS II-III Old Q-MI anterior wall EF- 50%

T wo Stent Strategy with DES and BVS for Left Main Bifurcation Treatment Indulis Kumsars, MD Latvian Centre of Cardiology Latvia
Clinical Characteristics  Male  69 y.o.  Stable angina CSS II-III  Old Q-MI anterior wall  EF- 50%  PCI with DES LAD 2011
LM before treatment
LCX ostium before treatment MLA 3.54 mm 2
PCI – Positioning of BVS Cutting balloon 3.25 – 10mm BVS 3.5 – 12mm
PCI – BVS post-dilatation NC 3.5 – 8mm
Result after BVS in LCX
PCI – DES LM - LAD Balloon 3.5 – 15mm DES 4.0 – 18mm
Kissing balloon dilatation Balloon 4.0 – 8mm - LAD Balloon 3.5 – 12mm – LCX POT 4.5- 8mm LM
Final result
IVUS in LCX after treatment LCX body LCX just after bifurcation
LM after treatment
OCT in LCX
OCT in LCX just after bifurcation
OCT in LM
Conclusions  Strategy with DES+ BVS could be effective treatment option in selected distal LM cases  IVUS and OCT are helpful additional tools in complex LM treatment

Recommend

P C R Randomized comparison of a sirolimus-eluting stent with a biolimus-eluting stent in

euro P C R Randomized comparison of a sirolimus-eluting stent with a biolimus-eluting stent in patients treated with PCI: the SORT OUT VII trial Lisette Okkels Jensen, Per Thayssen, Michael Maeng, Jan Ravkilde, Lars Krusell, Hans-Henrik

829 views • 14 slides

Choice of stent for AMI patients The University of Tokyo Hospital Jiro Ando, MD Which Stent we

Choice of stent for AMI patients The University of Tokyo Hospital Jiro Ando, MD Which Stent we can use in AMI BMS or DES ? Drug-Eluting Stents The Concept Stent design and delivery system Drug- Pharmacologic Drug carrier Eluting vehicle

568 views • 22 slides

IMC Titanium Stent long life reasonable cost IMC International Medical Contrivances 1 IMC

IMC Titanium Stent long life reasonable cost IMC International Medical Contrivances 1 IMC Cardiovascular Stent Type : Titanium Oxynitride Coating Stent Platform : 316 L Stainless steel alloy or L605 Cobalt Chromium Alloy Technology :

679 views • 42 slides

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions J. Mehilli, MD , G. Richardt, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim,

765 views • 27 slides

Jos PS Henriques, MD Jan Baan, MD Academic Medical Center Amsterdam, The Netherlands *DEB Not

DARE TRIAL A randomized comparison of paclitaxel-eluting balloon* versus everolimus-eluting stent for the treatment of any in-stent restenosis The DARE trial ( D rug-eluting b A lloon for in-stent Re stenosis) Jos PS Henriques, MD Jan Baan,

350 views • 21 slides

Onyx ONE A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. A Polymer-Free

Onyx ONE A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. A Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding on 1-Month DAPT Gilles Montalescot DOI @ action-coeur.org Stent comparisons with 1 month DAPT in HBR

556 views • 18 slides

Stent For Life, Egypt A Success Story Hany Ragy MD, FSCAI NHI, Cairo, Egypt @hragy Stent For

Stent For Life, Egypt A Success Story Hany Ragy MD, FSCAI NHI, Cairo, Egypt @hragy Stent For Life Initiative in Egypt Professor Mohamed Sobhy , MD, FACC, FESC Professor of Cardiology Department, Alexandria University - Egypt Past President

429 views • 30 slides

Isthmus Logic CoCr Balloon Expandable Stent for Iliac Arteries DS - 2018 Isthmus Logic

Isthmus Logic CoCr Balloon Expandable Stent for Iliac Arteries DS - 2018 Isthmus Logic Uniform increased radial force and excellent scaffolding with a unique cell architecture, ideal for calcified lesions. Platinum markers with no stent

287 views • 24 slides

Six-month versus 12-month dual-antiplatelet therapy following long everolimus-eluting stent

Six-month versus 12-month dual-antiplatelet therapy following long everolimus-eluting stent (total stent length >45mm) implantation: the IVUS-XPL randomized clinical trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial

598 views • 10 slides

ARCTIC investigators s ARCTIC : A ssessment by a double R andomization of a C onventional

ARCTIC investigators s ARCTIC : A ssessment by a double R andomization of a C onventional antiplatelet strategy versus a monitoring-guided strategy for drug-eluting stent implantation and, of T reatment I nterruption versus C ontinuation one year

496 views • 20 slides

Fenestrated and Branched Graft for TAAA: report of a case Melas N, Perdikides Th. History 1st

Fenestrated and Branched Graft for TAAA: report of a case Melas N, Perdikides Th. History 1st Fenestrated stent-graft, korea 1996 (1) fenestrated stent graft designed by D. Hartley 1997 1st publication of fenestrated stent graft:

559 views • 29 slides

TCT 2009 Back ground The efficacy of endovascular stent-graft placement for thoracic aortic

Midterm Outcome of Inoue Stent Graft for the Treatment of Thoracic Aortic Aneurysm and Dissections Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine Junichi Tazaki Takeshi Kimura Department of Cardiovascular

371 views • 20 slides

Results of histopathological thrombus evaluation in patients presenting with stent thrombosis

Results of histopathological thrombus evaluation in patients presenting with stent thrombosis across Europe: a report of the PRESTIGE Consortium Dr. med. Julia Riegger Medizinische Klinik u. Poliklinik I Ludwig-Maximilians-Universitt,

359 views • 22 slides

A NIGHTMARE FOR THE INTERVENTIONAL CARDIOLOGIST-DES STENT ANEURYSM! DR VARUN CHAWLA MD,DM

A NIGHTMARE FOR THE INTERVENTIONAL CARDIOLOGIST-DES STENT ANEURYSM! DR VARUN CHAWLA MD,DM LIFECARE INSTITUTE OF MEDICAL SCIENCES & RESEARCH,AHMEDABAD,INDIA Disclosure Statement of Financial Interest I, Dr Varun Chawla DO NOT have a

677 views • 32 slides

THE NEW NORMAL Opportunity Presentation Li fes most per si stent and ur gent questi on i s,

THE NEW NORMAL Opportunity Presentation Li fes most per si stent and ur gent questi on i s, W hat ar e you doi ng for other s D r . M a r t i n L u t h e r K i n g NetQube Office Baton Rouge, Louisiana USA 3 Meet The NetQube

578 views • 34 slides

How to treat SFA In-Stent Restenosis: Case Examples SCAI CPVI: SFA State-of-the-Art Treatment

How to treat SFA In-Stent Restenosis: Case Examples SCAI CPVI: SFA State-of-the-Art Treatment Strategies Andrew J. P. Klein, MD, FACC, FSCAI Interventional Cardiology Vascular and Endovascular Medicine Piedmont Heart Institute Atlanta, GA

437 views • 32 slides

Should I or Shouldnt I? Should I or Shouldnt I Associated Transverse Arch Stent a

Should I or Shouldnt I? Should I or Shouldnt I Associated Transverse Arch Stent a Coarctation of f Aorta Hypoplasia if its Associated with Transverse Arch Hypoplasia Darren P. Berman, MD Co-Director, Cardiac Catheterization The

881 views • 40 slides

Acute Stent Thrombosis Joo Heung Yoon, MD Sammy Elmariah, MD, MPH Ik-Kyung Jang, MD, PhD Di i i

Acute Stent Thrombosis Joo Heung Yoon, MD Sammy Elmariah, MD, MPH Ik-Kyung Jang, MD, PhD Di i i Division of Cardiology, Department of Medicine f C di l D t t f M di i Massachusetts General Hospital Harvard Medical School Boston MA

315 views • 27 slides

in Dependence on the Plasma Concentration of 37 Fatty Acids After the Coronary Stent Implantation

Inflammatory Markers in Dependence on the Plasma Concentration of 37 Fatty Acids After the Coronary Stent Implantation Ji Handl , Milan Meloun and Vladimra Mukov University of Pardubice, 532 10 Pardubice, Czech Republic Goal of

543 views • 15 slides

A CASE OF STENT THROMBOSIS CLAUDIA SERRANO, MD CLINICAL ASSISTANT PROFESSOR NYU LANGONE

A CASE OF STENT THROMBOSIS CLAUDIA SERRANO, MD CLINICAL ASSISTANT PROFESSOR NYU LANGONE Disclosures: I have nothing to disclose. 63 yo male Hypertension, and dyslipidemia Two recent long trips greater than 10 hours Presented

504 views • 24 slides

and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More Dariusz Dudek Institute of Cardiology, Krakow, Poland Disclosure Statement of Financial Interest I, Dariusz Dudek

564 views • 35 slides

Stent-based Stabilization of Ruptured Carotid Plaques: Clinical Lessons and Biomarkers Patterns

Stent-based Stabilization of Ruptured Carotid Plaques: Clinical Lessons and Biomarkers Patterns from the SUBMARINE Study, and Relevance to the Coronary Condition Giuseppe Sangiorgi, FESC, FSCAI San Raffaele Hospital and Emo Centro Cuore

358 views • 23 slides

Two Years Clinical Outcomes of Diabetic Patients Treated with a New Generation Drug-Eluting Stent

Two Years Clinical Outcomes of Diabetic Patients Treated with a New Generation Drug-Eluting Stent Francesco Saia Policlinico S.Orsola Malpighi, Bologna, Italy William Wijns, Ran Kornowski, Patrick Joly, Fraser Witherow, Enrique Novo Garcia,

575 views • 21 slides

Matthew T. Menard, M.D. Stenting In-stent restenosis Brigham and Womens Hospital University

4/15/2016 Matthew T. Menard, M.D. Stenting In-stent restenosis Brigham and Womens Hospital University of California San Francisco Vascular Symposium April 15, 2016 Bittl. NEJM 1996 Delivery of ionizing radiation through a directed

478 views • 9 slides